¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"oesophagus: scleroderma"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® scleroderma ÇÑ±Û °øÇÇÁõ
¼³¸í   
  ¸¸¼ºÀûÀ¸·Î °è¼Ó ÁøÇàµÇ¾î ÇǺΰ¡ µÎ²¨¿ö Áö°í µüµüÇØÁö´Â º´À¸·Î, ¼Ò¾Æ¿Í ¾î¸¥¿¡°Ô¼­ ¸ðµÎ ¹ß»ýÇÒ ¼ö ÀÖ°í, Æ¯Â¡ÀûÀ¸·Î ¸ñ°ú µîÀÇ À­ºÎºÐ¿¡¼­ ½ÃÀ۵ǾƷ¡Âʰú ¾ÕÂÊÀ¸·Î ÆÛÁö´Â º´ÀÌ´Ù. À̰ÍÀº ÀÏÁ¾ÀÇ ÀÚ°¡¸é¿ªÁúȯ(ÀÚ½ÅÀÇ ¼¼Æ÷¸¦ À̹°Áú·Î ÀÎÁöÇÏ¿© ¸é¿ª¹ÝÀÀÀ» ÀÏÀ¸Å°´Â Áúȯ)À¸·Î »ý°¢µÇ¸ç, ÇǺοܿ¡ ¶ÇÇÑ ³»ºÎ±â°ü(¿¹¸¦ µé¾î ÄáÆÏ, ÇãÆÄ, ½Äµµ µî)¿¡µµ ¿ª½Ã °°Àº ¹ÝÀÀÀÌ ÀϾ´Ù. Ä¡·á´Â Æ¯ÀÌÇÑ °ÍÀº ¾ø°í, ¸é¿ª¾ïÁ¦Á¦ÀÇ Ä¡·á¿Í ¹°¸®Ä¡·á µîÀ» ÅëÇÑ °í½ÄÀûÄ¡·á¿¡ ±×Ä£´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • circumscribed scleroderma
    ±¹ÇÑÇǺΰæÈ­Áõ, ±¹¼ÒÇǺΰæÈ­Áõ
  • diffuse scleroderma
    ±¤¹üÀ§ÇǺΰæÈ­Áõ
  • guttate scleroderma
    ¹æ¿ïÇǺΰæÈ­Áõ
  • linear scleroderma
    ¼±ÇǺΰæÈ­Áõ
  • localized scleroderma
    ±¹ÇÑÇǺΰæÈ­(Áõ)
  • scleroderma
    ÇǺΰæÈ­Áõ, ÇǺα»À½Áõ
  • scleroderma acrosclerosis
    ¸»´ÜÇǺΰæÈ­Áõ
  • scleroderma diabeticorum
    ´ç´¢ÇǺΰæÈ­Áõ
  • scleroderma en bande
    ¶ì¸ð¾çÇǺΰæÈ­Áõ
  • systemic scleroderma
    Àü½ÅÇǺΰæÈ­Áõ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • scleroderma
    ÇǺΰæÈ­Áõ, ÇǺα»À½Áõ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • circumscribed scleroderma
    (¢¡localized scleroderma) ±¹ÇÑÇǺΰæÈ­Áõ
  • diffuse scleroderma
    ±¤¹üÀ§ÇǺΰæÈ­Áõ
  • guttate scleroderma
    ¹æ¿ïÇǺΰæÈ­Áõ
  • linear scleroderma
    ¼±»óÇǺΰæÈ­Áõ
  • localized scleroderma
    ±¹ÇÑÇǺΰæÈ­Áõ
  • scleroderma
    ÇǺΰæÈ­Áõ, ÇǺα»À½Áõ
  • scleroderma acrosclerosis
    ¸»´ÜÇǺΰæÈ­Áõ
  • scleroderma diabeticorum
    ´ç´¢º´ÇǺΰæÈ­Áõ
  • scleroderma en bande
    ¶ì¸ð¾çÇǺΰæÈ­Áõ
  • systemic scleroderma
    Àü½ÅÇǺΰæÈ­Áõ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • guttate scleroderma
    ¹°¹æ¿ï °æÇÇÁõ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • oesophagus =esophagus ³ª
    ½Äµµ(ãÝÔ³).
  • circumscribed scleroderma
    ±¹ÇѼº) °æÇÇÁõ
  • diffuse scleroderma
    ±¤¹üÀ§ ÇǺΠ°æÈ­Áõ
  • familial scleroderma
    °¡Á·¼º ÇǺΠ°æÈ­Áõ
  • guttate scleroderma
    ¹°¹æ¿ï °æÇÇÁõ
  • linear scleroderma
    ¼±»ó °æÇÇÁõ
  • localized scleroderma
    ±¹ÇѼº°æÇÇÁõ
  • scleroderma
    ÇǺΰæÈ­Áõ
  • scleroderma
    ÇǺΰæÈ­Áõ,°æÇÇÁõ(Ìãù«ñø)
  • scleroderma
    ÇǺΰæÈ­Áõ(ù«Ý±Ìãûùñø), °æÇÇÁõ(Ìãù«ñø)
  • scleroderma acrosclerosis
    ¸»´Ü°æÇÇ(Áõ)
  • scleroderma diabeticorum
    ´ç´¢º´ °æÇÇ(Áõ)
  • scleroderma en bande
    ¶ì¸ð¾ç °æÇÇ(Áõ)
  • systemic scleroderma
    Àü½Å¼º °æÇÇÁõ(¡­Ìã ù«ñø)
  • systemic sclerosis [=scleroderma]
    Àü½Å¼º°æÈ­Áõ[= °æÇÇÁõ]
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • oesophagus
    ½Äµµ
  • scleroderma
    ÇǺΰæÈ­Áõ, °æÇÇÁõ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
oesoph esophagus [oesophagus]
DS dead air space; dead space; deep sedative; deep sleep; defined substrate; dehydroepiandrosterone sul...
LS lateral suspensor; left sacrum; left septum; left side; legally separated; leiomyosarcoma; length of...
LSc local scleroderma
PSS painful shoulder syndrome; physiologic saline solution; porcine stress syndrome; primary Sjogren syn...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
LS Localized scleroderma
PSS Progressive Systemic Scleroderma
SRC Scleroderma renal crisis
SSc; scleroderma Systemic Sclerosis
SSc Systemic scleroderma
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • circumscribed scleroderma
    ±¹ÇѼº °øÇÇÁõ
  • progressive scleroderma
    ÁøÇ༺ °øÇÇÁõ
  • scleroderma circumscripta
    ±¹ÇѼº °øÇÇÁõ
  • scleroderma in plaque
    ġų» °øÇÇÁõ
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
oesophagus: scleroderma <radiology> Females (80%), 35-55 years of age, decreased LES pressure, decreased peristalsis, smooth muscle atrophy with or without loose fibrosis, dermatomyositis may include involvement of upper 1/3 (striated), dysphagia to solids more than liquids (steakhouse syndrome), wide-open LES or HH, with or without basilar pulmonary fibrosis, other GI sites associated with CREST syndrome
(12 Dec 1998)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
progressive familial scleroderma A syndrome characterised by calcinosis cutis, Raynaud's phenomenon, sclerodactyly, and telangiectasia; usually due to scleroderma; autosomal dominant form of progressive systemic sclerosis.
(05 Mar 2000)
scleroderma <dermatology> Hardening of skin.
(04 Mar 1998)
scleroderma, circumscribed A chronic, localised hardening and thickening of the skin. Lesions may be categorised as morphea (guttate, profunda, pansclerotic) or linear (with or without melorheostosis or hemiatrophy). It is twice as common in women as in men. The condition is characterised by skin ischemia, lymphocytic infiltrates, swollen collagen bundles, and thickening of the dermis with reduction of subcutaneous fat.
(12 Dec 1998)
scleroderma, systemic A chronic, progressive dermatosis characterised by boardlike hardening and immobility of the affected skin, with visceral involvement, especially of lungs, oesophagus, kidneys and heart. It may be accompanied by calcinosis, raynaud's phenomenon, and telangiectasis (crest syndrome). It includes acrosclerosis and sclerodactyly.
(12 Dec 1998)
localised scleroderma A skin lesion that is characterised by the presence of localised, indurated, slightly depressed areas of thickened dermal tissue that may be white or yellow in colour and surrounded by a pink or purplish halo.
See: in cutaneus scleroderma.
(27 Sep 1997)
abdominal part of oesophagus The part of the oesophagus inferior to the diaphragm.
See: oesophagus.
Synonym: pars abdominalis oesophagi.
(05 Mar 2000)
adenocarcinoma in Barrett's oesophagus An adenocarcinoma arising in the lower third of the oesophagus that has become columnar cell lined (Barrett's mucosa) due to gastroesophageal reflux.
(05 Mar 2000)
barrett oesophagus <radiology> Replacement of squamous epithelium with columnar metaplasia in lower oesophagus, incidence: 2-10% of patients with reflux oesophagitis, associated with adenocarcinoma in 8-10% findings: large deep ulceration with or without stricture at distal/mid oesophagus, fine reticular pattern, commonly reflux, columnar epithelium secretes Tc-99m pertechnetate
(12 Dec 1998)
barrett's oesophagus A disorder in which the lining of the oesophagus undergoes cellular changes in response to chronic irritation and inflammation of reflux oesophagitis. This condition is more common in men than women. The patient with Barrett's oesophagus is at an increased risk of developing cancer of the oesophagus.
Symptoms are similar to those of reflux oesophagitis and include heartburn, difficulty swallowing and pain relief with antiacid use or eating. The diagnosis of Barrett's is made by a biopsy of the oesophageal mucosa through a endoscope.
Treatment includes control of reflux disease, weight reduction and avoidance of alcohol, tobacco, fatty foods and lying flat after eating. Close follow-up is recommended to be certain the individual does not develop cancer of the oesophagus.
(27 Sep 1997)
bullous diseases of oesophagus <radiology> Epidermolysis bullosa dystrophica, autosomal recessive, presents in infancy or later life, epidermal-dermal separation, with or without anal strictures, Treatment: conservative, soft diet, benign mucous membrane (cicatricial) pemphigoid, not pemphigus vulgaris, not bullous pemphigoid, females (2:1), elderly
(12 Dec 1998)
cancer, oesophagus Cancer of the swallowing tube that passes from the throat to the stomach. The risk of cancer of the oesophagus is increased by long-term irritation of the oesophagus, such as with smoking, heavy alcohol intake, and Barrett's oesophagitis. Cancer of the oesophagus can cause difficulty and pain with swallowing solid food. Diagnosis of oesophageal cancer can be made by barium X-ray of the oesophagus, and confirmed by endoscopy with biopsy of the cancer tissue.
(12 Dec 1998)
candidiasis of oesophagus <radiology> Findings: long oesophageal segments involved (more common in lower 1/2), 1-2 mm nodular filling defects with linear orientation (plaques), cobble stone: mucosal nodularity in early stage, shaggy, fuzzy, serrated contour (from pseudomembranes, erosions, ulcerations, intramural hemmorhage), narrowed lumen (spasm, pseudomembrane, oedema), intramural diverticulosis, sluggish/absent peristalsis Differential diagnosis: reflux oesophagitis, herpes oesophagitis, acute caustic ingestion, intramural pseudotics, squamous papillomatosis, glycogen acanthosis, Barrett oesophagus, superficial spreading carcinoma, epidermolysis bullosa, varices diagnostic sensitivity: endoscopy (97%), double contrast (88%), single contrast (55%)
(12 Dec 1998)
cardiac glands of oesophagus Gland's located in the lamina propria of the uppermost and lowermost levels of the oesophagus; they resemble cardiac gland's of the stomach in that they are branched tubules of mucous cells.
(05 Mar 2000)
mega-oesophagus <radiology> Achalasia, Chagas disease, idiopathic pseudo-obstruction, amyloidosis, Ehlers-Danlos syndrome, presbyesophagus (uncommon), oesophageal dysmotility (usually mild to moderate dilatation)
(12 Dec 1998)
cervical oesophagus The part of the oesophagus that goes through the neck.
(09 Oct 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • oesophagus
    =Esophagus
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á